top of page

About Dr Niti Raizada

MD, DNB, DM, ECMO, MRCP(UK), EMPH(US)
Senior Director, Medical Oncology and Hemato Oncology- Fortis group of Hospitals, Bangalore

Dr Niti Raizada is the Senior Director of Medical Oncology and Hemato Oncology, and Transplant Physician at Fortis Hospital, Bannerghatta Road, Bengaluru. She has 22 years of experience and manages over:

  • 12,000 Chemotherapies, Biologic Therapies, and Immunotherapies every year

  • 5,000 Bone marrow procedures, including Intrathecal, Intraperitoneal, and Intrapleural chemotherapies

  • 300 Stem Cell Transplants (Allogeneic and Autologous)

​

Dr Niti has led pioneering efforts in new drug discoveries through clinical trials, from Phase 1 to Phase 4, and has extensive experience managing patients from pediatric to geriatric age groups. She played a pivotal role in establishing a premier Oncology Unit at Vikram Hospital, Bengaluru, and advancing the Cancer Institute at Fortis Hospital.


Social Welfare Initiative:

  • Chief Trustee of National Research Network & Cancer Foundation, a charitable trust supporting cancer research and providing care for underprivileged cancer patients.

  • (2010 - Ongoing) - Initiated the Pink Hope Breast Cancer Support Group an initiative by surviving breast cancer patients to counsel new patients

  • (2014 – Ongoing) - Founder – National Research Network and Cancer Foundation, a charitable trust to support underprivileged cancer patients for treatment 

Expertise with 22 Years of Experience

Dr Niti Raizada brings over two decades of specialized experience in Medical Oncology, Hemato-Oncology, and Transplantation, providing cutting-edge treatment for a wide range of cancers.

Comprehensive & Compassionate Care

With a holistic approach to patient care, Dr Niti combines advanced therapies like chemotherapy, immunotherapy, and stem cell transplants with personalized treatment plans tailored to each patient's unique needs.

Leader in Clinical Research & Innovation

As a pioneer in clinical trials and new drug discoveries, Dr Niti stays at the forefront of medical advancements, ensuring her patients have access to the latest and most effective cancer treatments.

Education

  • (1992 - 1997) - Bachelor of Medicine and Bachelor of Surgery (MBBS – MD) from Gandhi Medical College, Bhopal, MP, India

  • (1999 - 2002) - Doctor of Medicine, General Medicine - Post Graduate (MD) from GR Medical College, Gwalior, MP, India.

  • (2004 - 2007) - Doctorate in Medicine (DM) Medical Oncology from Cancer Institute (WIA) Dept of Medical Oncology, Chennai, India

  • (2020 - 2021) - Executive Management Program in Healthcare: Management Essentials; Collaboration & Influence (e-MBA) Darden, University of Virginia, USA

After completing her MD in General Medicine & DNB while in her tenure at AIIMS, New Delhi, she went ahead to complete DM in Medical Oncology from the prestigious Adyar Cancer Institute, Chennai followed by a fellowship in Bone Marrow Transplant (Stem cell Transplant) from Imperial College and Hammersmith Hospital, London, UK.  Dr Niti is also accredited with MRCP (Medical Oncology) by the Royal College of Physicians, the UK in 2017.  Dr Niti has European Society of Medical Oncology (ESMO) certification given at Stockholm, Sweden in 2008 and Re-certified in 2015. 

Work Experience 

  • 2003 - Associate Consultant - Department of Medical Oncology, Indraprastha Apollo Hospitals, New Delhi  

  • (2007 - 2011) - Consultant Medical Haem-Oncology, Healthcare Global Enterprises (HCG), Bangalore, India - Head, Centre of Breast Health and Cancer Genetic Counseling Clinic; Head, Preventive Oncology 

  • (2011 - 2017) - Senior Consultant, Medical Oncology & Haem-Oncology, Fortis Hospitals, Bangalore, India   

  • (2011 - Current) - Head of Department, Medical Oncology & Haem-Oncology, Fortis group of  Hospitals, Bengaluru, India 

  • (2017 - 2019) - Senior Consultant, Medical Oncology & Haem-Oncology, Healthcare Global Enterprises (HCG), Bengaluru

  • (2019 - Current) - Director, Medical Oncology and Haemato-Oncology, Fortis Hospitals, Bengaluru, India

  • Other Experience (1992- 1997) - Vice President, General Secretary, Joint Secretary, Gandhi Medical College, Bhopal, MP, India

Honors & Awards

  • 1998 - President of India Award for All-Round Best Performance in All of MBBS

  • 1998 - Kak Memorial Award for All-Round Best Performance in All of MBBS 

  • 1998 - Gold Medal in MBBS aggregate 

  • (1993 - 1998) - Gold Medals in Anatomy, Biochemistry, Pathology, Forensic Medicine, Ophthalmology, Surgery and Medicine (Total of 18 Gold Medals in Medical College)

  • 2019 - Times Health Excellence Award for Service Excellence in Oncology 

  • 2022 - Garden City University Award on 12th International Women’s Day

Certification

  • 2004 - Diplomate National Board (DNB) in Internal Medicine - National Academy of Medical Sciences, New Delhi, India

  • 2005 - Member of Royal College of Physicians (MRCP) UK Part II 

  • 2008 - ESMO Certification - Sweden ESMO Congress, Stockholm, Sweden

  • 2015 - ESMO Re-Certification

  • 2017 - MRCP Speciality Certificate Exam (Medical Oncology) - Royal College of Physician, London

Memberships

  • American Society of Clinical Oncology (ASCO), USA, Full Member (72104) 

  • Royal College of Physicians, Edinburgh, UK 

  • Full Member European Society of Medical Oncology, ESMO (21922)

Teaching Experience 

  • (1999 - 2002) - Teaching Registrar, Department of Medicine, G R Medical College, Gwalior, MP, India  

  • 2007 - Assistant Professor, Medical Oncology, Adyar Cancer Institute, Chennai, India 

  • (2011 - 2013) - Assistant Professor, Medical Oncology, MVJ Medical College, Bangalore, India

  • PG Teaching Program:  Medical Oncology& Hemato- Oncology DNB as Teaching faculty. 

Training

  • 1998 - Internship - Gandhi Medical College, Bhopal, MP, India  

  • 2002 - Post-Graduate Trainee - Dept of Medical Oncology and Haemato-Oncology (IRCH), All India Institute of Medical Sciences (AIIMS), New Delhi, India

  • 2003 - Honorary Clinical Attachment - Department of Haematology, Imperial College & Hammersmith Hospital, London, UK 

  • 2004 - Senior Resident - Dept of Gastroenterology, All India Institute of Medical Sciences (AIIMS), New Delhi, India

  • 2021- IMPACT Training- Integrated Module of Palliative Care in Cancer Treatment, Pune (Cipla in association with SAARC Federation of Oncologists)

Clinical Trials

1. Principal Investigator, first/ second-line metastatic renal cell carcinoma (PhaseIII)-Global Sponsor 
2. Principal Investigator, Recurrent Cervix Cancer, Phase III, Global Sponsor 
3. Principal Investigator, CIAtrial, PhaseIII, GlobalSponsor 
4. Principal Investigator, Metastatic Breast Cancer, Phase III, Global Sponsor 
5. Principal Investigator, Phase I/II Trial for the investigational Targeted drug along with Herceptin in Newly diagnosed Metastatic Breast Cancer- Global sponsor 
6. Principal Investigator, Phase II trial with investigational agent along with Paclitaxel and carboplatin in LABC / Metastatic Breast cancer-GlobalSponsor v Principal Investigator, Phase III trial in Relapsed and Refractory Non-Hodgkin’s Lymphoma with Rituximab and anti-CD 22 MAB compared to investigator choice of Chemo agent – Global Sponsor 
7. Principal Investigator, Phase III trial in Metastatic RCC with Temsirolimus and Bevacizumab- Global Sponsor 
8. Co-Investigator, Phase III Trial with the investigational agent along with Carboplatin / Docetaxel compared to Docetaxel/ carboplatin in Advanced Non-Small Cell Lung cancer patients. Global Sponsor 
9. Co-Investigator, PET CT Study with new radionucleotide (integrin based), Global Sponsor 
10. Co-Investigator, Carcinoma Cervix Concurrent Chemoradiation (Cisplatin Vs Cisplatin and Nimotuzumab) 
11. Principal Investigator, Cancer Pain study, Global Sponsor 
12. Principal Investigator – Capecitabine Bioequivalence Study, MBC and CRC (Medical Device) 
13. Principal Investigator - Metastatic Colorectal Cancer with Liver Metastasis, Phototherapy 
14. Co-Investigator – Xeloda and Avastin Maintenance in Metastatic Breast Cancer, Global Sponsor 
15. Principal Investigator - NSCLC: Afatinib (two): Global sponsor 
16. Principal Investigator - ADD Aspirin Trial - Collaboration with MRC, UK, 2019 
17. Co-Investigator - Radiomics Siemens, Europe, 2019 
18. Principal Investigator - Avastin in Ovarian Cancer, 2019 
19. Principal Investigator - PIK3A Inhibitor in TNBC, Global Sponsor 2019

19. Principal Investigator - Pan india - newer Antifungal 2020
20. Principal Investigator- Global - Myelofibrosis refractory to JAKi
21. Principal Investigator- Global Trial - Advanced Ca Ovary - Newer Biological
22. Principal Investigator- Global - New Hormonal Therapy- Adjuvant Carcinoma Breast

23. Principal Investigator in more than 60 Global Multicentric Trials in past 22 years

Editorial Board

She is also on the Editorial Board of eminent international Journals and many publications to her credit in national and international journals and presentations in International Conferences. 

  • (2010 - 2019) - Healthcare Global Newsletter (HCG Quarterly Communiqué) - Chief Editor 


  • (2011 - Current) - Journal of Medical Science and Research: Journal publishes original scientific papers

  • (2018 - Current) - Journal of Precision Oncology (Wolter Kluwer Publishing Company) - Scientific Editor
    ​

Posters and Oral Presentations

1. 2008 ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer, 30th Oct – 1st Nov 2008, Florida, USA - Her/neu overexpression due to Polysomy 17 in Breast Cancer. Can molecular testing guide the therapeutic options? Authors: G. V. Patil, J. D. Kulkarni, A. Korlimarla, C. Vatte, S. Rao, J. Prabhu, N.R.Narang, R. Sahoo; Triesta Sciences, Bangalore, India 
2. Breast Cancer Symposia, ASCO, September 2008, Washington DC, USA- Poster Presentation-Abst. ID: 86 (Temp. Abst. ID: 40400)-18FDG PET/CT as a useful pre- chemotherapeutic tool in carcinoma breast evaluation. Authors: N Raizada, K. Kallur, M. Govindrajan, G. Prashanth, K. Nagaraj, S. Bhattacharjee, B. Ajai Kumar 
3. American Society of Clinical Oncology (ASCO), June 2008, Chicago USA- Poster Presentation- Effects of pretreatment, pharmacologic factors, and yoga intervention on CINV outcomes in breast cancer. Raghavendra, Niti Raizada, Shekhar Patil, Ravi Diwakar, Ajai Kumar 
4. American Society of Clinical Oncology (ASCO), GI Symposium, San Francisco, USA, 28th Jan 2006 - Poster Presentation & Virtual Meeting -Preoperative Multimodality therapy for optimising clinical benefit in locally advanced Carcinoma Rectum. Authors: Niti Raizada, S. G. Ramanan, T.G. Sagar, Rambha Pandey, Vikas Mahajan, A.Vasanthan 
5. UICC (International Union against Cancer), Washington DC, USA, July 2006 - Oral Presentation- ACRAL EWING’S SARCOMA-Typical Bone Tumor at Unusual Location. Author: Dr Niti Raizada, Dr Anita Chandra, Dr T.G. Sagar 
6. INCTR (International Network for Cancer Treatment and Research), Sao Paulo, Brazil, March 2007- Poster presentation- Dermatotoxicity of Imatinib Mesylate in Adult Chronic Myeloid Leukemia. Authors: Niti Raizada, TG Sagar 
7. Indian Cooperative Oncology Network (ICON), 13th ICON Meet, Vellore, TN, India. September 16-18, 2005. Awarded SECOND prize and cash award for the best project titled “Preoperative (Neoadjuvant) Chemoradiotherapy in Carcinoma Rectum and assessment of the prognostic significance of molecular markers for response prediction on post-operative histopathology.” Chief Investigator: Niti Raizada 
8. Cardiological Society of India, Kochi, December 2002, Oral Presentation in the Echocardiography session – “Echocardiographic Study of LVPW Thickness & IVS. Thickness in patients with Type 2 DM with reference to Albuminuria”. Authors: Niti Raizada, Puneet Rastogi, SB Gupta 
9. EACR-ESMO Joint Conference on Liquid Biopsies Bergamo, Italy 15th May 2019 - 17th May 2019, Poster Presentation. Non-invasive detection and monitoring of response and resistance to therapy in non-small cell lung cancer(NSCLC) using circulating tumour DNA (ct DNA) as “Liquid Biopsy”. Authors: Mithua Ghosh, Yogesh Shivakumar, Shekhar Patil, Sateesh CT, Radheshyam Naik, Niti Raizada, Srinivas BJ, Sridhar PS, Renjan Thomas 
10. Annual Meeting Program of American Society for Radiation Oncology (ASTRO) Chicago, September 15-18 2019, Poster Presentation. Mapping of EGFR Mutations in Lung Cancer on CT Scans Using Quantitative Radiomic Feature Modeling - Pilont Indian Study. Authors: Lohith G, Shivakumar Swamy, Niti Raizada, Basavalinga Ajai Kumar

11. Lymphoma Leukaemia Myeloma Congress October 18-22 2022, New York, Abstract: CD5 Negative Mantle Cell Lymphomas: A Trivial aberration or a variation of significance? Authors: Kunal Sharma, Niti Raizada, & others

Publications and Book Chapters

1. Indian Heart Journal. Sept-Oct 2002; Vol 54; No.5 [K-153]. ‘Echocardiographic Study of Left Ventricular Posterior Wall Thickness and Interventricular Septal Thickness in Patients with Type 2 Diabetes Mellitus with Reference to Albuminuria’. 
2. 35th ESMO Congress Abstract Book, a supplement to the official ESMO journal Annals of Oncology 2010 Baseline presentation of Triple-negative breast cancer (TNBC) and Her2+/neu breast cancer at a centre in South India, Type: publication (Breast cancer, Advanced), N Raizada Narang, M. KB, T. Thomas, A. Kumar BS; Bangalore/IN. 
3. ORAL ONCOLOGY JOURNAL, Elsevier Journal, (August 2009) Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary Ca larynx Niti Raizada, PC Jain, SB Gupta, P Rastogi. 
4. CHAPTER IN API TEXTBOOK OF MEDICINE, VIII Edition (Under print)- ‘Epidemiology & Etiology of Cancer’, TG Sagar, Niti Raizada Narang 
5. ASCO Proceedings 2008, Abstract no.[9599] Effects of pretreatment, pharmacologic factors, and yoga intervention on CINV outcomes in breast cancer. Authors: R. M. Raghavendra, B. S. Ajaikumar, S. Patil, D. B. Ravi, R.N.Niti, K. S. Gopinath, S. B. Srinath 
6. ACRAL EWING’S SARCOMA-‘Typical Bone Tumor at Unusual Location’ Author: Niti Raizada, Anita Chandra, T.G. Sagar, UICC Conference proceedings, full review (FREE PAPERS). 
7. ASCO Proceedings, 2007- “Imatinib Mesylate, Safety and Efficacy in Pediatric and Adult Chronic Myeloid Leukemia”, Niti Raizada, TG Sagar 
8. ASCO Proceedings, 2008(JCO, 20th May 2008)- 22160-Abstract Title: ‘A study of mood states and diurnal salivary cortisol rhythms in breast cancer patients awaiting radiotherapy: A cross-sectional study’. N Raizada, H. S. Vadiraja, R. M. Raghavendra, B. S. Ajaikumar, R. S. Bilimagga, M. Rekha, N Vanitha, N. Usha, R. Nagarathna, H. R. Nagendra 
9. Book: Recent advances in Molecular Imaging & Radiation Oncology (2009), Dr Kumara Swamy, Dr Kallur, Dr Niti Raizada, Dr Lokesh, Dr Janaki, Dr Vijay Bhaskar 

10. Lancet Oncol. 2015 Aug ;16(8):897-907. Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-lung 8): an open-label randomised controlled phase 3 trial
11. Biomedical Journal of Scientific & Technological Research 30th Oct 2018, Concomitant Venous Thromboembolism (VTE) with cancer and its effect on survival in Indian Patients. Authors: G Lohith, Radheshyam Naik, Shekar Patil, Niti Raizada, Amrit Ram, Sudhakar Sampangi, Shivakumar Swamy and Basavalinga Ajai Kumar. Healthcare Global Enterprises Limited, Bangalore, India. 
12. Current Trends in Biomedical Engineering & Biosciences 17th Dec 2018, Artificial Intelligence (AI): Productive Progress in Radiation Oncology. Authors: G Lohith, Niti Raizada, Sudhakar Sampangi, Shivakumar Swamy and B Ajai Kumar 
13. Pre-invasive Breast Lesions: Detection and Management 18th May 2019, Preventive Oncology for the Gynaecologist, pp383-395. Authors: Sumit Goyal, Niti Raizada Publisher: Springer 
14. The Journal of Obstetrics and Gynecology of India, July 2019 - Pregnancy in a Rare Case of Intracranial Rosai Dorfman Disease (RDD). Authors: Shashikala Ksheerasagar, N Venkatesh, Niti Raizada, K M Prathima, Ravindara B Kamble, K Srinivas, M A Suzi Jacklin, B A Chandramouli 
15. Urology Case Reports 33(2020) 101313 Oncology Radical Cystectomy with Ileal Neobladder in a patient with Hemophilia. A case report. Authors: Karthik Rao, Mohan Keshavamurthy, Shakir Tabrez, Sreeharsha Harinatha, Niti Raizada 

16. Pulmonary Enteric Adenocarcinoma Lung- Case Series & Approach to Diagnosis, Apr 2022 Annals of Case Reports Authors: Pupul Bose, Mohammed Zeba Shaffi, Niti Raizada, Veena Vanere, Kunal Sharma 
17. American Journal Of Hematology Vol 97 Issue S3 Oct 2022 Abstracts from the 2022 Lymphoma, Leukemia and Myeloma Congress October 18–22, 2022 CDS Negative Mantle Cell Lymphomas: a trivial aberration or a variation of significance? Authors: Sharma Kunal, Raizada Niti, Vanera Veena, Tikeykar Vishakha, et al
18. The Egypt Journal of Haematology 48_21 2022 Case Report A Rare Case of Disseminated Extranodal B-Cell Marginal Zone Lymphoma of the Larynx in an Adolescent girl. Ravi Joshi, Hamz Dala, Susheen Dutt… Niti Raizada
19. Journal of Clinical Oncology Vol 41 Issue 16 supplement 2023 Does the landscape of comprehensive genomic profiling in patients with advanced stage lung cancer in India differ from data from the western countries? Ankur Bahl, Niti Raizada, Aparna Dhar et al

Research Experience

1. DM Registrar (Clinical Fellow) Thesis title: “Non-Hematological Toxicities of Imatinib Mesylate in Adult & Pediatric Chronic Myeloid Leukemia.” Advisor: Professor T.G. Sagar MD, DM 
2. Project: “Preoperative (Neoadjuvant) Chemoradiotherapy in Carcinoma Rectum and assessment of the prognostic significance of molecular markers for response prediction on post-operative histopathology”. Advisor: Dr S.G Ramanan MD, DM 
3. Thesis work as MD Internal Medicine Resident: “Echocardiographic Study of Left Ventricular Posterior Wall Thickness & Interventricular Septal Thickness in patients with Type 2 Diabetes Mellitus with reference to Albuminuria”. Advisor: Associate Professor Puneet Rastogi MD, DM, Professor S.B. Gupta MD

bottom of page